Family Med Medical News about Encephalitis, Japanese Vaccines

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Development of a vaccine to prevent Japanese encephalitis: a brief review
International Journal of General Medicine, 10/16/09

Wiwanitkit V – Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper management to deal with this virus is essential. There is no specific treatment for Japanese encephalitis virus. Supportive and symptomatic treatments are usually used, which emphasize the importance of prevention in this specific neurological disorder. Vector control or vaccination can be used to prevent the disease. Because the existing Japanese encephalitis vaccine poses some undesirable problems, a new vaccine is needed. The process of developing a new vaccine is briefly discussed.

<< Previous
Adipose tissue distribution after weight restoration and weight...

Next >>
Vulnerability and the ‘slippery slope’ at the end-of-life: a...

Ixiaro: a new vaccine against Japanese encephalitis
Expert Review of Vaccines, 10/29/09 Relevance Score: 80%

GSKs Cervarix becomes the first cervical cancer vaccine to gain approval in Japan
GlaxoSmithKline, 10/19/09 Relevance Score: 67%

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09 Relevance Score: 49%

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09 Relevance Score: 49%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09 Relevance Score: 48%